Literature DB >> 27981731

Robotic salvage retroperitoneal and pelvic lymph node dissection for 'node-only' recurrent prostate cancer: technique and initial series.

Andre Abreu1, Carlos Fay1,2, Daniel Park1, David Quinn1, Tanya Dorff1, John Carpten1, Peter Kuhn1, Parkash Gill1, Fabio Almeida1, Inderbir Gill1.   

Abstract

OBJECTIVES: To describe the technique of robot-assisted high-extended salvage retroperitoneal and pelvic lymphadenectomy (sRPLND+PLND) for 'node-only' recurrent prostate cancer. PATIENTS AND METHODS: In all, 10 patients underwent robot-assisted sRPLND+PLND (09/2015-03/2016) for 'node-only' recurrent prostate cancer, as identified by 11 C-acetate positron emission tomography/computed tomography imaging. Our anatomical template extends from bilateral renal artery/vein cranially up to Cloquet's node caudally, completely excising lymphatic-fatty tissue from aorto-caval and iliac vascular trees; RPLND precedes PLND. Meticulous node-mapping assessed nodes at four prospectively assigned anatomical zones.
RESULTS: The median operative time was 4.8 h, estimated blood loss 100 mL and hospital stay 1 day. No patient had an intraoperative complication, open conversion or blood transfusion. Three patients had spontaneously resolving Clavien-Dindo grade II postoperative complications. The mean (range) number of nodes excised per patient was 83 (41-132) and mean (range) number of positive nodes per patient was 23 (0-109). Seven patients (70%) had positive nodes on final pathology. Node-positive rates per anatomical level I, II, III and IV were 28%, 32%, 33% and 33%, respectively. In patients with positive nodes, the median PSA level had decreased by 83% at the 2-month follow-up.
CONCLUSION: The initial series of robot-assisted sRPLND+PLND is presented, wherein we duplicate open surgery with superior nodal counts and decreased morbidity. Robot-assisted technical details for an anatomical LND template up to the renal vessels are presented. Longer follow-up is necessary to assess oncological outcomes.
© 2016 The Authors BJU International © 2016 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  #PCSM; #ProstateCancer; robot-assisted surgery; salvage PLND; salvage RPLND

Mesh:

Year:  2017        PMID: 27981731      PMCID: PMC9084626          DOI: 10.1111/bju.13741

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.969


  12 in total

1.  Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.

Authors:  R Jeffrey Karnes; Christopher R Murphy; Eric J Bergstralh; Guy DiMonte; John C Cheville; Val J Lowe; Lance A Mynderse; Eugene D Kwon
Journal:  J Urol       Date:  2014-08-20       Impact factor: 7.450

Review 2.  Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature.

Authors:  Guillaume Ploussard; Christophe Almeras; Alberto Briganti; Gianluca Giannarini; Christophe Hennequin; Piet Ost; Raphaële Renard-Penna; Ambroise Salin; Thierry Lebret; Arnauld Villers; Michel Soulié; Alexandre de la Taille; Vincent Flamand
Journal:  J Urol       Date:  2015-05-09       Impact factor: 7.450

3.  Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.

Authors:  Patrizio Rigatti; Nazareno Suardi; Alberto Briganti; Luigi F Da Pozzo; Manuela Tutolo; Luca Villa; Andrea Gallina; Umberto Capitanio; Firas Abdollah; Vincenzo Scattoni; Renzo Colombo; Massimo Freschi; Maria Picchio; Cristina Messa; Giorgio Guazzoni; Francesco Montorsi
Journal:  Eur Urol       Date:  2011-08-03       Impact factor: 20.096

4.  Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.

Authors:  David Schilling; Heinz P Schlemmer; Philipp H Wagner; Patrick Böttcher; Axel S Merseburger; Philip Aschoff; Roland Bares; Christa Pfannenberg; Ute Ganswindt; Stefan Corvin; Arnulf Stenzl
Journal:  BJU Int       Date:  2008-04-11       Impact factor: 5.588

5.  [11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.

Authors:  Ludwig Rinnab; Felix M Mottaghy; Joerg Simon; Bjoern G Volkmer; Robert de Petriconi; Richard E Hautmann; Markus Wittbrodt; Guenther Egghart; Peter Moeller; Norbert Blumstein; Sven Reske; Rainer Kuefer
Journal:  Urol Int       Date:  2008-08-29       Impact factor: 2.089

6.  Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer.

Authors:  C A Jilg; H C Rischke; S N Reske; K Henne; A-L Grosu; W Weber; V Drendel; M Schwardt; A Jandausch; W Schultze-Seemann
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

Review 7.  Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy.

Authors:  Firas Abdollah; Alberto Briganti; Francesco Montorsi; Arnulf Stenzl; Christian Stief; Bertrand Tombal; Hein Van Poppel; Karim Touijer
Journal:  Eur Urol       Date:  2014-03-26       Impact factor: 20.096

8.  Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.

Authors:  Alexander Winter; Rolf-Peter Henke; Friedhelm Wawroschek
Journal:  BMC Urol       Date:  2015-02-21       Impact factor: 2.264

9.  Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome.

Authors:  Tom Claeys; Charles Van Praet; Nicolaas Lumen; Piet Ost; Valérie Fonteyne; Gert De Meerleer; Bieke Lambert; Louke Delrue; Pieter De Visschere; Geert Villeirs; Karel Decaestecker
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

10.  Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.

Authors:  Nazareno Suardi; Giorgio Gandaglia; Andrea Gallina; Ettore Di Trapani; Vincenzo Scattoni; Damiano Vizziello; Vito Cucchiara; Roberto Bertini; Renzo Colombo; Maria Picchio; Giampiero Giovacchini; Francesco Montorsi; Alberto Briganti
Journal:  Eur Urol       Date:  2014-02-18       Impact factor: 20.096

View more
  6 in total

1.  [When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?]

Authors:  A Kretschmer; A Herlemann; C G Stief; C Gratzke
Journal:  Urologe A       Date:  2017-05       Impact factor: 0.639

2.  Image-guided percutaneous targeting of lymph nodes: a novel approach for salvage pelvic lymphadenectomy in recurrent prostate cancer.

Authors:  Gustavo Caserta Lemos; Arie Carneiro; Guilherme Cayres Mariotti; Jose Roberto Colombo; Marcelo Apezzato; Marcelo Livorsi da Cunha; Fernado Cotait Maluf; Rodrigo Gobbo Garcia
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

3.  18F-choline positron emission tomography/computed tomography guided laparoscopic salvage lymph node dissection in patients after radical prostatectomy.

Authors:  Markiian Kubis; Krystian Kaczmarek; Artur Lemiński; Marcin Słojewski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-11-13       Impact factor: 1.195

4.  Extended robotic salvage lymphadenectomy in patients with 'node-only' prostate cancer recurrence: initial experience.

Authors:  Konstantin Kolontarev; Alexander Govorov; George Kasyan; Paul Rasner; Alexander Vasiliev; Dmitry Pushkar
Journal:  Cent European J Urol       Date:  2018-06-12

Review 5.  Role of salvage lymph node dissection in patients previously treated for prostate cancer: systematic review.

Authors:  João Paulo Pretti Fantin; Maria Claudia Bicudo Furst; Marcos Tobias-Machado; Roberto Lodeiro Muller; Roberto Dias Machado; Alexandre Cesar Santos; Wesley Justino Magnabosco; Cinthia Alcantara-Quispe; Eliney Ferreira Faria
Journal:  Int Braz J Urol       Date:  2021 May-Jun       Impact factor: 1.541

6.  68Ga-PSMA ligand PET/CT integrating indocyanine green-guided salvage lymph node dissection for lymph node metastasis after radical prostatectomy.

Authors:  Teng-Cheng Li; Yu Wang; Chu-Tian Xiao; Ming-Zhao Li; Xiao-Peng Liu; Wen-Tao Huang; Liao-Yuan Li; Ke Li; Jin-Ming Di; Xing-Qiao Wen; Xin Gao
Journal:  Asian J Androl       Date:  2022 Jan-Feb       Impact factor: 3.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.